University of Saskatchewan

September 23, 2014   

Fast Facts about INTERVAC

InterVac (International Vaccine Centre) is a $140 million vaccine research and development centre to be built at the University of Saskatchewan, next to VIDO and connected to it via a walkway. InterVac will develop vaccines to protect people and animals from the threat of emerging or persistent diseases such as avian influenza or tuberculosis. This new facility will be the first Containment Level 3 facility in Western Canada dealing with both human and large animal diseases. InterVac will enhance a cluster of world-class life sciences research capacity on the University of Saskatchewan campus that is unique in North America.

InterVac Overview

Contact Us

(image of Architect's
rendering of InterVac facility)

Architect's rendering of the new centre
AODBT in association with Smith Carter